Safety and tolerability of once-weekly administration of CTP-modified human growth hormone (MOD-4023): phase 2 study in children with growth hormone deficiency

Autor:	Zvi Zadik, Oren Hershkovitz, Ron G. Rosenfeld, Julia Skorodok, Leanne Amitzi, Violeta Iotova, Oleg Malievsky, Gili Hart, Nataliya Zelinska, Ronit Koren, Klaudziya Radziuk
Rok vydání:	2016
Předmět:	medicine.medical_specialty Endocrinology Tolerability business.industry Internal medicine Human growth hormone medicine Phases of clinical research Once weekly business medicine.disease Growth hormone deficiency
Zdroj:	Endocrine Abstracts.
ISSN:	1479-6848
DOI:	10.1530/endoabs.41.ep845
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3f69b854d43644dbe00d5d4a8134643a https://doi.org/10.1530/endoabs.41.ep845 Zobrazit plný text záznamu